RESTON, Va., Dec. 23, 2019 /PRNewswire/ — Leidos (NYSE: LDOS), Intel Corporation, and First Genesis today announced their collaborative approach in developing blockchain technologies to improve healthcare has earned the American Council for Technology and Industry Advisory Council’s (ACT-IAC) 2019 Audience Choice Award. The effort sees Leidos, Intel Corporation, and First Genesis working together to enable healthcare data exchange and inter-operability among different electronic healthcare record (EHR) or electronic record management (ERM) systems that serves the interests of patients and clinical research.
The team’s winning submission was selected from among nine finalists who submitted presentations on the application of blockchain for government missions. The team’s presentation addressed inter-operability challenges in the current IT infrastructure that make it difficult to report and share health information data and clinical trial results. As a result, the solution provides a secure platform to seamlessly exchange health information data and clinical trial results across diverse healthcare providers.
“This was truly a collective effort by the Leidos, Intel and First Genesis team,” said Doreen Cohen, Leidos Health Group’s senior vice president of Government Health and Safety Solutions. “We are thrilled to be recognized for what we feel is game-changing technology that advances public health and safety.”
“The collaboration between Intel, Leidos and First Genesis uses the unique advantages of blockchain technology to deliver interoperability across multiple EHR systems, a major challenge to scaling the benefits of electronic records,” said Ray Yep, director of Federal Health at Intel. “The solution, built on 2nd generation Intel Xeon Scalable processors and Intel Optane SSDs, offers the performance and scalability to help make blockchain-based multi-provider ERM a reality in the marketplace.”
“We have architected our Blockchain Platform as a…